Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Matsoukas

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry|April 24, 2018
Cyclization of PLP<sub>139-151</sub> peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitisAthanasios Lourbopoulos, Minos-Timotheos Matsoukas, Maria Katsara, et al.
Expert Review of Vaccines|June 9, 2025
Control measures for neglected tropical diseases: vaccine updatesVivek P Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Vaccines|December 28, 2021
Myelin Peptide-Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine IngredientJohn Matsoukas, George Deraos, Kostas Kelaidonis, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 26, 2010
Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancerTheodora Katsila, Evangelos Balafas, George Liapakis, et al.
European Journal of Medicinal Chemistry|September 24, 2024
Tetrazoles: A multi-potent motif in drug designYe Yuan, Muzi Li, Vasso Apostolopoulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 3, 2012
Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune diseaseMarianna Ioannou, Themis Alissafi, Iakovos Lazaridis, et al.
European Journal of Medicinal Chemistry|August 15, 2012
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivativesGeorge Agelis, Amalia Resvani, Serdar Durdagi, et al.
Journal of Computer-Aided Molecular Design|November 2, 2011
Conformational studies of immunodominant myelin basic protein 1-11 analogues using NMR and molecular modelingDespina Laimou, Eliada Lazoura, Anastassios N Troganis, et al.
Journal of Medicinal Chemistry|January 11, 2002
Antagonistic effects of human cyclic MBP(87-99) altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferationTheodore Tselios, Vasso Apostolopoulos, Ioanna Daliani, et al.
Current Molecular Pharmacology|April 21, 2018
Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood VesselsMichaila Michalatou, Maria Eleni Androutsou, Markos Antonopoulos, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|April 24, 2018
Cyclization of PLP<sub>139-151</sub> peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitisAthanasios Lourbopoulos, Minos-Timotheos Matsoukas, Maria Katsara, et al.
Expert Review of Vaccines|June 9, 2025
Control measures for neglected tropical diseases: vaccine updatesVivek P Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Vaccines|December 28, 2021
Myelin Peptide-Mannan Conjugate Multiple Sclerosis Vaccines: Conjugation Efficacy and Stability of Vaccine IngredientJohn Matsoukas, George Deraos, Kostas Kelaidonis, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 26, 2010
Evaluation of a stable gonadotropin-releasing hormone analog in mice for the treatment of endocrine disorders and prostate cancerTheodora Katsila, Evangelos Balafas, George Liapakis, et al.
European Journal of Medicinal Chemistry|September 24, 2024
Tetrazoles: A multi-potent motif in drug designYe Yuan, Muzi Li, Vasso Apostolopoulos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 3, 2012
Crucial role of granulocytic myeloid-derived suppressor cells in the regulation of central nervous system autoimmune diseaseMarianna Ioannou, Themis Alissafi, Iakovos Lazaridis, et al.
European Journal of Medicinal Chemistry|August 15, 2012
The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivativesGeorge Agelis, Amalia Resvani, Serdar Durdagi, et al.
Journal of Computer-Aided Molecular Design|November 2, 2011
Conformational studies of immunodominant myelin basic protein 1-11 analogues using NMR and molecular modelingDespina Laimou, Eliada Lazoura, Anastassios N Troganis, et al.
Journal of Medicinal Chemistry|January 11, 2002
Antagonistic effects of human cyclic MBP(87-99) altered peptide ligands in experimental allergic encephalomyelitis and human T-cell proliferationTheodore Tselios, Vasso Apostolopoulos, Ioanna Daliani, et al.
Current Molecular Pharmacology|April 21, 2018
Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood VesselsMichaila Michalatou, Maria Eleni Androutsou, Markos Antonopoulos, et al.
Pageof 7